Clinical Restrictions - PULOX PO-200 Manual De Instrucciones

interference may also affect the accuracy.
7. Testee can not use enamel or other makeup.

3.3 Clinical Restrictions

1. As the measure is taken on the basis of arteriole pulse,
substantial pulsating blood flow of subject is required. For a
subject with weak pulse due to shock, low ambient/body
temperature, major bleeding, or use of vascular contracting
drug, the SpO
the measurement will be more sensitive to interference.
2. For those with a substantial amount of staining dilution drug
(such as methylene blue, indigo green and acid indigo blue),
or carbon monoxide hemoglobin (COHb), or methionine
(Me+Hb) or thiosalicylic hemoglobin, and some with icterus
problem, the SpO
inaccurate.
3. The drugs like dopamine, procaine, prilocaine, lidocaine and
butacaine may also be a major factor blamed for serious error
of SpO
4. As the SpO
of anemic anoxia and toxic anoxia, some patients with serious
anemia may also report good SpO
4. Technical Specifications
A. Display Format: OLED Display
SpO2 Measuring range: 0 ~100 %
Pulse Measuring range: 30bpm ~250bpm
Perfusion Index Measuring Range: 0% ~ 20%
Pulse Wave Display: columniation display and the waveform
display
B. Power Requirements: 2 ×1.5V AAA alkaline battery (or using
the rechargeable battery instead), adaptable range:
2.6V~3.6V.
C. Power Consumption: Smaller than 30mA
D. Resolution: SpO2: 1%, Pulse: 1bpm, Perfusion Index: 0.1%.
E. Measurement Accuracy: ±2% in stage of 70%-100% SpO2,
and meaningless when stage being smaller than 70%. ± 2 bpm
during the pulse rate range of 30-99 bpm and ± 2% during the
pulse rate range of 100~250 bpm
F. Measurement Performance in Weak Filling Condition: SpO2
and pulse rate can be shown correctly when pulse-filling ratio
waveform (PLETH) will decrease. In this case,
2
determination by this monitor may be
2
measure.
2
value serves as a reference value for judgement
2
measurement.
2
EN